{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:09:22Z","timestamp":1776330562086,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101539 and 82101539"],"award-info":[{"award-number":["82101539 and 82101539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["M2022107 and BJ20003"],"award-info":[{"award-number":["M2022107 and BJ20003"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Trials from the Affiliated Drum Tower Hospital","award":["2022-LCYJ-PY-11"],"award-info":[{"award-number":["2022-LCYJ-PY-11"]}]},{"name":"the Jiangsu Province Stroke Association","award":["JSSA20230010Y and JSSA2024ZD01"],"award-info":[{"award-number":["JSSA20230010Y and JSSA2024ZD01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10072-025-08290-9","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:36:33Z","timestamp":1749422193000},"page":"4593-4599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Frequency of anti-GQ1b IgG antibody in Miller Fisher syndrome: a Chinese single center study"],"prefix":"10.1007","volume":"46","author":[{"given":"Pengfei","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"6","key":"8290_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A CHIBA","year":"1992","unstructured":"Chiba A, Kusunoki S, Shimizu T et al (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome [J]. Ann Neurol 31(6):677\u2013679","journal-title":"Ann Neurol"},{"issue":"5","key":"8290_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00415-008-0775-0","volume":"255","author":"M ITO","year":"2008","unstructured":"ITO M, Kuwabara S, Odaka M et al (2008) Bickerstaff\u2019s brainstem encephalitis and fisher syndrome form a continuous spectrum: clinical analysis of 581 cases [J]. J Neurol 255(5):674\u2013682","journal-title":"J Neurol"},{"issue":"1","key":"8290_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10072-018-3580-2","volume":"40","author":"JH JUNG","year":"2019","unstructured":"JUNG JH, OH E H, SHIN JH et al (2019) Atypical clinical manifestations of Miller Fisher syndrome [J]. Neurol Sci 40(1):67\u201373","journal-title":"Neurol Sci"},{"issue":"5","key":"8290_CR4","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1128\/IAI.67.5.2414-2420.1999","volume":"67","author":"B SCHWERER","year":"1999","unstructured":"Schwerer B, Neisser A, Bernheimer H (1999) Distinct Immunoglobulin class and Immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection [J]. Infect Immun 67(5):2414\u20132420","journal-title":"Infect Immun"},{"issue":"3","key":"8290_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000226599","volume":"62","author":"JM SAN-JUAN O D, MARTINEZ-HERRERA J F,","year":"2009","unstructured":"San-Juan O D, Martinez-Herrera J F, Garcia JM et al (2009) Miller Fisher syndrome: 10 years\u2019 experience in a third-level center [J]. Eur Neurol 62(3):149\u2013154","journal-title":"Eur Neurol"},{"issue":"2","key":"8290_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jns5.12030","volume":"18","author":"BAI H X","year":"2013","unstructured":"Bai H X, Wang Z L, Tan L M et al (2013) The effectiveness of Immunomodulating treatment on Miller Fisher syndrome: a retrospective analysis of 65 Chinese patients [J]. J Peripher Nerv Syst 18(2):195\u2013196","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"8290_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10072-017-3184-2","volume":"39","author":"Q HU","year":"2018","unstructured":"Hu Q, Li H, Tian J et al (2018) Bulbar paralysis associated with Miller-Fisher syndrome and its overlaps in Chinese patients [J]. Neurol Sci 39(2):305\u2013311","journal-title":"Neurol Sci"},{"issue":"7","key":"8290_CR8","doi-asserted-by":"publisher","first-page":"300060523118911","DOI":"10.1177\/03000605231189114","volume":"51","author":"M CHI","year":"2023","unstructured":"Chi M, Zhu Hanl (2023) Anti-GT1a and anti-GQ1b Immunoglobulin G antibody positivity with overlapping Miller Fisher\/Guillain-Barre syndromes and prominent headache: a case report [J]. J Int Med Res 51(7):3000605231189114","journal-title":"J Int Med Res"},{"issue":"23","key":"8290_CR9","first-page":"1800","volume":"99","author":"JX YIN","year":"2019","unstructured":"Yin JX, YU C Y Huangl et al (2019) [Clinical analysis of 8 cases with anti-GQ1b antibody syndrome] [J]. Zhonghua Yi Xue Za Zhi 99(23):1800\u20131804","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"8290_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s13760-022-01940-1","volume":"123","author":"X WU","year":"2023","unstructured":"Wu X, Wang Y, XI ZQ (2023) Clinical and antibodies analysis of anti-GQ1b antibody syndrome: a case series of 15 patients [J]. Acta Neurol Belg 123(3):839\u2013847","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"8290_CR11","first-page":"e12424","volume":"13","author":"S KAJANI","year":"2021","unstructured":"Kajani S, Kajani R, Huang C W et al (2021) Miller Fisher syndrome in the COVID-19 Era - A novel target antigen calls for novel treatment [J]. Cureus 13(1):e12424","journal-title":"Cureus"},{"issue":"5","key":"8290_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/ane.13687","volume":"146","author":"JE KIM","year":"2022","unstructured":"Kim JE, Yoon B A, Kim Y H et al (2022) Miller Fisher syndrome following COVID-19 vaccines: A scoping review [J]. Acta Neurol Scand 146(5):604\u2013609","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"8290_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"A WAKERLEY B R, UNCINI","year":"2014","unstructured":"Wakerley B R, Uncini A, Yuki N et al (2014) Guillain-Barre and Miller Fisher syndromes\u2013new diagnostic classification [J]. Nat Rev Neurol 10(9):537\u2013544","journal-title":"Nat Rev Neurol"},{"issue":"19","key":"8290_CR14","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/WNL.0000000000002558","volume":"86","author":"R SPATOLA M D, PASQUIER","year":"2016","unstructured":"Spatola M D, Pasquier R (2016) Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes. Neurology 86(19):1780\u20131784","journal-title":"Neurology"},{"key":"8290_CR15","doi-asserted-by":"publisher","first-page":"843260","DOI":"10.3389\/fneur.2022.843260","volume":"13","author":"P SHAO","year":"2022","unstructured":"Shao P, Xu H (2022) Lobar cerebral microbleeds are associated with cognitive decline in patients with type 2 diabetes mellitus. Front Neurol 13:843260","journal-title":"Front Neurol"},{"issue":"1","key":"8290_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","volume":"6","author":"HJ WILLISON","year":"1999","unstructured":"Willison Hj, Veitch J, Swan AV (1999) Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 6(1):71\u201377","journal-title":"Eur J Neurol"},{"issue":"7","key":"8290_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21037\/atm-20-2285","volume":"11","author":"W ZHU","year":"2023","unstructured":"Zhu W, LI K, Cui T et al (2023) Detection of anti-ganglioside antibodies in Guillain-Barre syndrome [J]. Ann Transl Med 11(7):289","journal-title":"Ann Transl Med"},{"issue":"2","key":"8290_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0022-1759(93)90348-B","volume":"165","author":"F CHABRAOUI","year":"1993","unstructured":"Chabraoui F, Derrington Ea, Mallie-Didier F (1993) Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes. J Immunol Methods 165(2):225\u2013230","journal-title":"J Immunol Methods"},{"issue":"2","key":"8290_CR19","first-page":"117","volume":"7","author":"MR BONYADI","year":"2010","unstructured":"Bonyadi Mr, Barzegar M (2010) Comparison of Immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome. Iran J Immunol 7(2):117\u2013123","journal-title":"Iran J Immunol"},{"issue":"12","key":"8290_CR20","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/ene.16073","volume":"30","author":"VAN DOORN P A","year":"2023","unstructured":"Van Doorn P A, Van Den Bergh P Y K, Hadden R D M et al (2023) European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barre syndrome [J]. Eur J Neurol 30(12):3646\u20133674","journal-title":"Eur J Neurol"},{"issue":"6","key":"8290_CR21","doi-asserted-by":"publisher","first-page":"2125753","DOI":"10.1080\/21645515.2022.2125753","volume":"18","author":"H LIANG","year":"2022","unstructured":"Liang H, Cao Y, Zhong W et al (2022) Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: case report and scope review [J]. Hum Vaccin Immunother 18(6):2125753","journal-title":"Hum Vaccin Immunother"},{"issue":"34","key":"8290_CR22","doi-asserted-by":"publisher","first-page":"e34969","DOI":"10.1097\/MD.0000000000034969","volume":"102","author":"L ZHANG","year":"2023","unstructured":"Zhang L, Ma L, Zhou L et al (2023) Miller-Fisher syndrome with positive anti-GD1b and anti-GM1 antibodies combined with multiple autoimmune antibodies: A case report [J]. Med (Baltim) 102(34):e34969","journal-title":"Med (Baltim)"},{"key":"8290_CR23","doi-asserted-by":"publisher","first-page":"814453","DOI":"10.3389\/fneur.2021.814453","volume":"12","author":"N CHEN","year":"2021","unstructured":"Chen N, Cai H (2021) Case report: A patient diagnosed with Miller Fisher syndrome and myasthenia Gravis at the same time [J]. Front Neurol 12:814453","journal-title":"Front Neurol"},{"issue":"3","key":"8290_CR24","doi-asserted-by":"publisher","first-page":"300060519867490","DOI":"10.1177\/0300060519867490","volume":"48","author":"LIU Y M","year":"2020","unstructured":"Liu Y M, Chen Y L, Deng Y H et al (2020) Miller Fisher syndrome with early intracranial hypertension and delayed bilateral simultaneous facial nerve palsy: a case report [J]. J Int Med Res 48(3):300060519867490","journal-title":"J Int Med Res"},{"key":"8290_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/1756-0500-5-295","volume":"5","author":"C HAN","year":"2012","unstructured":"Han C, Wang Y, Jia J et al (2012) Bickerstaff\u2019s brainstem encephalitis, Miller Fisher syndrome and Guillain-Barre syndrome overlap in an asthma patient with negative anti-ganglioside antibodies [J]. BMC Res Notes 5:295","journal-title":"BMC Res Notes"},{"issue":"9","key":"8290_CR26","doi-asserted-by":"publisher","first-page":"e9824","DOI":"10.1097\/MD.0000000000009824","volume":"97","author":"C JING","year":"2018","unstructured":"Jing C, Wang Z, Chu C et al (2018) Miller-Fisher syndrome complicated by Bickerstaff brainstem encephalitis: A case report [J]. Med (Baltim) 97(9):e9824","journal-title":"Med (Baltim)"},{"issue":"5","key":"8290_CR27","doi-asserted-by":"publisher","first-page":"e24451","DOI":"10.1097\/MD.0000000000024451","volume":"100","author":"L CHANG","year":"2021","unstructured":"Chang L, Xiong J, Xue Y et al (2021) An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report [J]. Med (Baltim) 100(5):e24451","journal-title":"Med (Baltim)"},{"issue":"37","key":"8290_CR28","doi-asserted-by":"publisher","first-page":"e30584","DOI":"10.1097\/MD.0000000000030584","volume":"101","author":"M ZHAO","year":"2022","unstructured":"Zhao M, Gu Y, Zhao J et al (2022) AntiGQ1b antibody positive with MFS\/GBS overlapped syndrome with diplopia and hemiplegia onset: case report and retrospective analysis [J]. Med (Baltim) 101(37):e30584","journal-title":"Med (Baltim)"},{"issue":"5","key":"8290_CR29","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s10072-024-07300-6","volume":"45","author":"J CHEN","year":"2024","unstructured":"Chen J, Tian M (2024) Only anti-GM4 antibody positivity in a Chinese Girl with overlapping MFS\/GBS: a case report [J]. Neurol Sci 45(5):2331\u20132335","journal-title":"Neurol Sci"},{"issue":"2","key":"8290_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3988\/jcn.2021.17.2.273","volume":"17","author":"TAN C Y","year":"2021","unstructured":"Tan C Y, Razali S N O, Goh K J et al (2021) Determining the utility of the Guillain-Barre syndrome classification criteria [J]. J Clin Neurol 17(2):273\u2013282","journal-title":"J Clin Neurol"},{"issue":"7","key":"8290_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00415-011-6360-y","volume":"259","author":"M KOGA","year":"2012","unstructured":"Koga M, Gilbert M, Takahashi M et al (2012) GQ1b-seronegative fisher syndrome: clinical features and new serological markers [J]. J Neurol 259(7):1366\u20131374","journal-title":"J Neurol"},{"key":"8290_CR32","doi-asserted-by":"crossref","unstructured":"Patel K, Nussbaum E, Sico J et al (2020) Atypical case of Miller-Fisher syndrome presenting with severe dysphagia and weight loss [J]. BMJ Case Rep, 13(5)","DOI":"10.1136\/bcr-2020-234316"},{"issue":"5","key":"8290_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/head.13320","volume":"58","author":"P MORENO-AJONA D, IRIMIA","year":"2018","unstructured":"Moreno-Ajona D, Irimia P, Fernandez-Matarrubia M (2018) Headache and ophthalmoparesis: case report of an atypical incomplete Miller-Fisher syndrome [J]. Headache 58(5):746\u2013749","journal-title":"Headache"},{"key":"8290_CR34","doi-asserted-by":"publisher","first-page":"911175","DOI":"10.3389\/fmed.2022.911175","volume":"9","author":"DO ROSARIO M S","year":"2022","unstructured":"Do Rosario M S, De Jesus P A P, Farias D S et al (2022) Guillain-Barre syndrome and Miller Fisher syndrome in association with an arboviral outbreak: A Brazilian case series [J]. Front Med (Lausanne) 9:911175","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"8290_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3988\/jcn.2021.17.4.541","volume":"17","author":"MARTINS-FILHO P R","year":"2021","unstructured":"Martins-Filho P R, Pereira De Andrade A L, Pereira De Andrade A J et al (2021) Miller Fisher syndrome in patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review [J]. J Clin Neurol 17(4):541\u2013545","journal-title":"J Clin Neurol"},{"key":"8290_CR36","doi-asserted-by":"crossref","unstructured":"Poyraz T. Miller Fisher syndrome associated with COVID-19: A history of molecular mimicry and an Up-to-Date review of the literature [J]. Cureus, (2023) 15(8): e43111","DOI":"10.7759\/cureus.43111"},{"issue":"6","key":"8290_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.72.6.767","volume":"72","author":"M KOGA","year":"2002","unstructured":"Koga M, Yoshino H, Morimatsu M et al (2002) Anti-GT1a IgG in Guillain-Barre syndrome [J]. J Neurol Neurosurg Psychiatry 72(6):767\u2013771","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08290-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08290-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08290-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:15:08Z","timestamp":1757182508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08290-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["8290"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08290-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}